GSK3735967
Based on 1 publication(s) in Google Scholar
GSK3735967 is an selective, reversible, non-nucleoside inhibitor of DNMT1 with an IC50 value of 40 nM. GSK3735967 contains a planar dicyanopyridine core that can specifically embed DNMT1 bound hemimethylated CpG dinucleotides. GSK3735967 has three binding sites, one of which can bind to histone H4K20me3.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.34%
- CAS No.: 2170136-86-2
- 화학식: C25H31N7OS
- 분자량:477.62
-
보관:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
-
HY-139664
GSK-3685032DNMT1 Inhibitor -
HY-13642
RG108DNMT Inhibitor -
HY-B2230
HinokitiolVirus Protease Inhibitor -
HY-151136
DY-46-2DNMT3A Inhibitor -
HY-129079A
TFMB-(S)-2-HGAnti-cancer Agent -
HY-12746
DC-05DNA Methyltransferase Inhibitor -
HY-B2194
γ-OryzanolDNA Methyltransferase Inhibitor -
HY-103397
Nanaomycin ANatural Product -
HY-13668
LomeguatribMGMT Inhibitor -
HY-111558A
Bobcat339 hydrochlorideTET Inhibitor -
HY-116217
5-Fluoro-2'-deoxycytidineDNMT Inhibitor -
HY-144433
DNMT3A-IN-1DNMT3A Inhibitor
Publications Citing Use of MedChemExpress (MCE) GSK3735967
MoreAll DNA Methyltransferase Isoforms
More
Biological Activity
제품 설명
In Vitro
Chemical Information
-
CAS No. 2170136-86-2
-
Appearance Solid
-
분자량 477.62
-
화학식 C25H31N7OS
-
Color Off-white to yellow
-
SMILES
N#CC1=C(SCC2=CC=C(CNC(CN)=O)C=C2)N=C(N3CCN(CCC3)C)C(C#N)=C1CC
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
bioRxiv
2024 Apr 3:2024.04.03.587980. PMID: 38617249
용액&용해도
In Vitro:
DMSO : 31.25 mg/mL (65.43 mM; ultrasonic and warming and heat to 70°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (4.35 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.08 mg/mL (4.35 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.0937 mL | 10.4686 mL | 20.9371 mL | 52.3429 mL |
| 5 mM | 0.4187 mL | 2.0937 mL | 4.1874 mL | 10.4686 mL | |
| 10 mM | 0.2094 mL | 1.0469 mL | 2.0937 mL | 5.2343 mL | |
| 15 mM | 0.1396 mL | 0.6979 mL | 1.3958 mL | 3.4895 mL | |
| 20 mM | 0.1047 mL | 0.5234 mL | 1.0469 mL | 2.6171 mL | |
| 25 mM | 0.0837 mL | 0.4187 mL | 0.8375 mL | 2.0937 mL | |
| 30 mM | 0.0698 mL | 0.3490 mL | 0.6979 mL | 1.7448 mL | |
| 40 mM | 0.0523 mL | 0.2617 mL | 0.5234 mL | 1.3086 mL | |
| 50 mM | 0.0419 mL | 0.2094 mL | 0.4187 mL | 1.0469 mL | |
| 60 mM | 0.0349 mL | 0.1745 mL | 0.3490 mL | 0.8724 mL |
GSK3735967 Related Classifications
HY-150249 Related Classifications
Powered by Bioz